Carcinoma of the anal canal is an uncommon malignancy, accounting for only 1-3% of colorectal cancers (Goligher, 1984) . Flow cytometric DNA analysis has attracted interest as a possible prognostic tool in patients with colorectal cancer (Wolley et al., 1982; Armitage et al., 1985; Kokal et al., 1986; Quirke et al., 1987; Scott et al., 1987a, b tional 28 patients had been fixed continuously in formalin for a penrod of several years. As the tumour tissue of these 28 patients would not stain satisfactonrly with propidium iodide (Schutte et al., 1985) , they also had to be excluded from the study.
contrast, no similar role has been claimed for flow cytometric DNA analysis in patients with an anal canal cancer.
We successfully produced DNA ploidy histograms from the anal canal cancers of 117 patients. Our aim was to discover whether the DNA ploidy pattern of an anal canal cancer is related to clinicopathological features of this malignancy and or patient prognosis.
Materials and methods
Patients with an anal canal cancer treated primarily at the Mayo Clinic between January 1950 and December 1981 were considered eligible for this study. The total group numbered 220 patients and included 188 patients previously reported (Boman et al., 1984) along with 32 more recent cases. Anal canal cancers arose in the surgical anal canal between the anal verge and the puborectalis muscle. Carcinomas of the lower rectum and perianal skin were excluded.
As described previously (Boman et al., 1984) A 40ym thick section was cut from the original paraffin embedded block of the anal cancer. This was processed to give a suspension of cell nuclei (Hedley et al., 1983 ) which was stained with propidium iodide (Vindelov et al., 1983 tional 28 patients had been fixed continuously in formalin for a penrod of several years. As the tumour tissue of these 28 patients would not stain satisfactonrly with propidium iodide (Schutte et al., 1985) , they also had to be excluded from the study.
A (Tribukait et al., 1982) . in the absence of aggregation (no 6c peak), were classified as DNA tetraploid; this category of DNA tetraploid included 20 anal cancers. The DNA histograms of the remaining 18 anal carcinomas were of such poor quality that they could not be classified.
Statistical analyses were carred out using the SAS procedures (SAS Program Institute, 1986) . The program FREQ was used to test associations of clinicopathological features of the anal canal cancers with their DNA pattern. All P values were determined using the Pearson X2 statistic. The survival curves were generated using the Kaplan-Meier method (Kaplan & Meier, 1958) , and univariate survival comparisons were made using the log-rank statistic (Mantel & Haenszel, 1959) . Multivariate analyses were done using the program PHGLM to fit a Cox proportional hazards model (Cox, 1972) . A backward regression was used to find the most significant factors, variables being eliminated based on the MLE statistics. This process stopped when all MLE statistics were significant at the 0.05 level. Two-sided P values based on the y2 score statistic were used for terms in the Cox model.
Results
Patient age, sex and tunour size
No association was seen between patient sex and the DNA ploidy pattern of an anal canal cancer (Table I) . Similarly, little correlation was seen between tumour ploidy and patient age, although younger patients (less than 45 years) had proportionately more DNA non-diploid patterns (Table I) . Large anal cancers (greater than 5cm diameter) gave more DNA non-diploid patterns than smaller anal cancers (Table I) . The large majority of grade 1 and 2 squamous cell carcinomas were DNA diploid. Almost one-third of the grade 3 and 4 squamous cell carcinomas and the non-keratinising basaloid carcinomas were DNA non-diploid. Small cell carcinomas gave the largest proportion (40%) of DNA non-diploid patterns (Table I) .
Among the 117 anal canal carcinomas, the large majority of stage A, stage Bl and stage B2 cancers were DNA diploid. By contrast, nearly one-third of those anal carcinomas that had invaded through the sphincter or spread to lymph nodes were DNA non-diploid (Table I ). The largest proportion of DNA non-diploid patterns was seen in tumours that had metastasised to distant sites. Therapy and tumour recurrence Seventeen patients (15%) of the 117 studied had their anal carcinoma locally excised, 94 (80%) had abdominoperineal excision of the rectum. and in six (5%) biopsy or some other surgical procedure was done. One (7%) of 13 DNA diploid cancers locally excised suffered a local recurrence. Although only two DNA non-diploid cancers were treated by local excision, one (50%) recurred locally. There was little difference in the rates of local recurrence after abdominoperineal resection -32% for DNA diploid anal cancers and 26% for DNA non-diploid cancers (Table II) .
Nineteen patients received radiotherapy along with their surgical procedure. Local recurrence was less commonly seen with DNA diploid anal cancers so treated (21%) than with similarly managed DNA non-diploid cancers -60% local recurrence (Table III) . Only one patient of the 117 studied received chemotherapy. (Table I) .
Patients with a DNA diploid anal cancer had a survival advantage (66% alive at 5 years) over patients with a DNA non-diploid anal cancer (52% alive at 5 years) (P=0.08) (Figure la) . Of the DNA non-diploid anal cancers, those with a DNA aneuploid histogram were associated with the poorest prognosis -43% alive at 5 years, P=0.037 (Figure lb) . Among grade 1 and 2 squamous cell cancers, non-keratinising basaloid cancers, and small cell cancers, there was a trend for DNA non-diploid cancers to have the poorest prognosis. Little prognostic effect was seen for DNA ploidy pattern among grade 3 and 4 squamous cell tumours.
Similarly, tumour DNA ploidy pattern was not associated with any prognostic differences in patients with a stage B anal cancer. In patients with stage C or stage D anal cancer, DNA non-diploid cancers tended to be associated with the worst prognosis, but this never reached statistical significance.
Multivariate analysis was performed for all 117 patients. The variables considered were patient sex, patient age, tumour histology, tumour stage and DNA ploidy pattern.
The independent prognostic vanrable of greatest significance in this analysis was the tumour cell histology type, small cell cancer. The DNA ploidy pattern of an anal cancer was not of independent prognostic significance.
Dison
The 117 anal cancer patients described in this report represent only one-half of the patients considered eligible for study. Despite the highly selective nature of the group studied here, the prognostic importance of tumour histology and stage was again demonstrated (Boman et al., 1984) . By Despite this latter finding, DNA aneuploid anal cancers were associated with a poor prognosis in this study. However, they accounted for only 13% of all anal cancers, an incidence much lower than that reported for colorectal adenocarcinomas (Armitage et al., 1985) . Others using flow cytometric DNA analysis have failed to demonstrate any DNA aneuploid histograms in even poorly differentiated squamous cell carcinomas of the anus (Fenger & Bichel, 1981) . By contrast the very different technique and criteria of photographic cytophotometry classifies most squamous cell anal cancers as aneuploid (Goldman et al., 1987) . But even with this much higher incidence of aneuploidy, this latter study could still not demonstrate any correlation between the ploidy of anal cancers and patient prognosis (Goldman et al., 1987) .
Interestingly, small cell cancers of the anus had both the worst prognosis here and the highest proportion of the DNA non-diploid ploidy patterns. This latter finding may be a reflection of the increased aggressiveness of these small cell tumours. Similar small cell lung cancers have an even higher incidence (over 80%) of DNA non-diploid ploidy patterns (Bunn et al., 1983) .
The primary treatment of the large majority of patients in this study was surgical, in contrast to the modern multimodality therapy of anal cancer (Nigro, 1987) . Thus, it is difficult to extrapolate the findings of this study with regard to DNA ploidy patterns to the present day management of anal cancers. However, it was noteworthy that local recurrence of an anal cancer was more common after local excision and after combined surgical and radiation treatment if the cancer was DNA non-diploid.
It may, therefore, be worth including the DNA ploidy pattern of an anal cancer as a pathological factor in future prospective trials that seek to evaluate anal cancer treatment regimens. This would only be possible if the DNA analysis of anal cancer biopsies was shown to be both feasible and reproducible.
